Filed: 5/15/2023ACC: 0001214659-23-007162
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $695.01M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$695.01M
Total AUM (reported)
48.92M
Total Shares
Allocation by class
COM$559.79M80.5%
SPONSORED ADS$53.31M7.7%
COM NEW$46.63M6.7%
SHS$28.81M4.1%
CL A$6.17M0.9%
ORD SHS$300.1K0.0%
Portfolio Concentration
Top 3$323.00M46.5%
4–10$217.50M31.3%
11–25$130.61M18.8%
Rest$23.90M3.4%
Top 3 weight
46.5%
Top 10 weight
77.8%
Voting Authority Distribution
Total shares with voting rights: 48.92M
Sole
Full voting authority
48.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares3.25M
TypeSH
Market value$214.37M
30.84%
Sole
3.25M
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares2.55M
TypeSH
Market value$59.07M
8.50%
Sole
2.55M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares2.47M
TypeSH
Market value$49.56M
7.13%
Sole
2.47M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares4.57M
TypeSH
Market value$39.86M
5.73%
Sole
4.57M
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares2.17M
TypeSH
Market value$39.62M
5.70%
Sole
2.17M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.19M
TypeSH
Market value$30.15M
4.34%
Sole
1.19M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares3.90M
TypeSH
Market value$28.81M
4.15%
Sole
3.90M
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$27.89M
4.01%
Sole
750K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares759.90K
TypeSH
Market value$27.34M
3.93%
Sole
759.90K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares1.44M
TypeSH
Market value$23.84M
3.43%
Sole
1.44M
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares474.93K
TypeSH
Market value$19.29M
2.78%
Sole
474.93K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares621.71K
TypeSH
Market value$12.54M
1.80%
Sole
621.71K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares6.38M
TypeSH
Market value$11.55M
1.66%
Sole
6.38M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares495K
TypeSH
Market value$11.13M
1.60%
Sole
495K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares1.20M
TypeSH
Market value$9.28M
1.34%
Sole
1.20M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares500K
TypeSH
Market value$8.59M
1.24%
Sole
500K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares596K
TypeSH
Market value$8.11M
1.17%
Sole
596K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares692.95K
TypeSH
Market value$7.98M
1.15%
Sole
692.95K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares2.42M
TypeSH
Market value$7.69M
1.11%
Sole
2.42M
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares375K
TypeSH
Market value$6.24M
0.90%
Sole
375K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares795K
TypeSH
Market value$6.17M
0.89%
Sole
795K
Shared
0.00
None
0.00
89BIO INC
SOLEShares400K
TypeSH
Market value$6.09M
0.88%
Sole
400K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares382K
TypeSH
Market value$5.86M
0.84%
Sole
382K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares94.70K
TypeSH
Market value$5.13M
0.74%
Sole
94.70K
Shared
0.00
None
0.00
GERON CORP
SOLEShares2.28M
TypeSH
Market value$4.94M
0.71%
Sole
2.28M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.25M | SH | $214.37M 30.84% | 3.25M | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 2.55M | SH | $59.07M 8.50% | 2.55M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 2.47M | SH | $49.56M 7.13% | 2.47M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 4.57M | SH | $39.86M 5.73% | 4.57M | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 2.17M | SH | $39.62M 5.70% | 2.17M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.19M | SH | $30.15M 4.34% | 1.19M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 3.90M | SH | $28.81M 4.15% | 3.90M | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 750K | SH | $27.89M 4.01% | 750K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 759.90K | SH | $27.34M 3.93% | 759.90K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 1.44M | SH | $23.84M 3.43% | 1.44M | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 474.93K | SH | $19.29M 2.78% | 474.93K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 621.71K | SH | $12.54M 1.80% | 621.71K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM | 6.38M | SH | $11.55M 1.66% | 6.38M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 495K | SH | $11.13M 1.60% | 495K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 1.20M | SH | $9.28M 1.34% | 1.20M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 500K | SH | $8.59M 1.24% | 500K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | COM | 596K | SH | $8.11M 1.17% | 596K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 692.95K | SH | $7.98M 1.15% | 692.95K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 2.42M | SH | $7.69M 1.11% | 2.42M | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 375K | SH | $6.24M 0.90% | 375K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 795K | SH | $6.17M 0.89% | 795K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 400K | SH | $6.09M 0.88% | 400K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 382K | SH | $5.86M 0.84% | 382K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 94.70K | SH | $5.13M 0.74% | 94.70K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 2.28M | SH | $4.94M 0.71% | 2.28M | 0.00 | 0.00 |
Page 1 of 2